Literature DB >> 10698047

Pituitary gonadal axis and child rate in males with classical 21-hydroxylase deficiency.

J Jääskeläinen1, O Kiekara, M Hippeläinen, R Voutilainen.   

Abstract

Though appropriate glucocorticoid substitution therapy should abolish both cortisol deficiency and adrenal androgen excess in patients with 21-hydroxylase deficiency (21-OHD), the long-term outcome is not always satisfactory. There are several reports on low adult height in both male and female patients, and impaired fertility has been reported in females with 21-OHD. There are only few reports on gonadal function of adult male patients with 21 -OHD. In this study, we calculated the child rate of all the 29 diagnosed adult Finnish males with classical 21-OHD and compared it with the mean child rate of the whole Finnish male population with equal age distribution. Sixteen males with 21-OHD and their age-matched healthy controls were further examined in a cross-sectional study. Auxology and pituitary gonadal axis were examined in both patients and controls. Testicular ultrasonography of the patients was also performed. The mean child rate of the 29 males with 21-OHD was 0.07 which was significantly lower (p<0.001) than that in the Finnish male population of the same age (0.34). In the cross-sectional study, males with 21-OHD had serum testosterone, inhibin B, LH and FSH concentrations comparable to those of healthy controls and reference values. Serum DHEA-S concentrations were remarkably low, even in the undersubstituted males with 21-OHD (p<0.001, compared with the healthy controls). In the patient group, serum inhibin B concentration did not correlate with serum FSH concentration. Adrenal rest tumors of the testicles were found in two undersubstituted males with 21-OHD. In conclusion, our study suggests normal pituitary and gonadal function but reduced child rate in adult males with 21-OHD. This might be explained by suboptimal psychosocial adaptation to the chronic disease. However, the patients in this study were young and the final child rate may become essentially higher.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698047     DOI: 10.1007/BF03343671

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

1.  Testicular adrenal-like tissue (TALT) in congenital adrenal hyperplasia: detection by ultrasonography.

Authors:  U Willi; M Atares; A Prader; M Zachmann
Journal:  Pediatr Radiol       Date:  1991

2.  Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency.

Authors:  J Jääskeläinen; R Voutilainen
Journal:  Clin Endocrinol (Oxf)       Date:  1996-12       Impact factor: 3.478

3.  Psychosexual adjustment in congenital adrenal hyperplasia.

Authors:  D D Federman
Journal:  N Engl J Med       Date:  1987-01-22       Impact factor: 91.245

4.  Testicular masses in association with adrenogenital syndrome: US findings.

Authors:  A Vanzulli; A DelMaschio; P Paesano; F Braggion; C Livieri; E Angeli; G Tomasi; C Gatti; F Severi; G Chiumello
Journal:  Radiology       Date:  1992-05       Impact factor: 11.105

5.  Gonadal and adrenal catheterization during adrenal suppression and gonadal stimulation in a patient with bilateral testicular tumors and congenital adrenal hyperplasia.

Authors:  M E Combes-Moukhovsky; M L Kottler; P Valensi; P Boudou; M Sibony; J R Attali
Journal:  J Clin Endocrinol Metab       Date:  1994-11       Impact factor: 5.958

6.  Testicular tumors in congenital adrenal hyperplasia: steroid measurements from adrenal and spermatic veins.

Authors:  J Blumberg-Tick; P Boudou; K Nahoul; G Schaison
Journal:  J Clin Endocrinol Metab       Date:  1991-11       Impact factor: 5.958

7.  Subnormal androgen and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency.

Authors:  J Helleday; B Siwers; E M Ritzén; K Carlström
Journal:  J Clin Endocrinol Metab       Date:  1993-04       Impact factor: 5.958

8.  Congenital adrenal hyperplasia with testicular tumors, aggression, and gonadal failure.

Authors:  E J Keely; I Matwijiw; J A Thliveris; C Faiman
Journal:  Urology       Date:  1993-04       Impact factor: 2.649

9.  Benign testicular tumors in children with congenital adrenal hyperplasia.

Authors:  M S Srikanth; B R West; M Ishitani; H Isaacs; H Applebaum; G Costin
Journal:  J Pediatr Surg       Date:  1992-05       Impact factor: 2.545

10.  Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  R M Mulaikal; C J Migeon; J A Rock
Journal:  N Engl J Med       Date:  1987-01-22       Impact factor: 91.245

View more
  14 in total

Review 1.  Adrenal steroidogenesis and congenital adrenal hyperplasia.

Authors:  Adina F Turcu; Richard J Auchus
Journal:  Endocrinol Metab Clin North Am       Date:  2015-06       Impact factor: 4.741

Review 2.  A review and practical application of evidence based medicine (EBM): Testicular adrenal rest tumour.

Authors:  Amir M I Babiker
Journal:  Sudan J Paediatr       Date:  2012

Review 3.  Clinical outcomes in the management of congenital adrenal hyperplasia.

Authors:  Henrik Falhammar; Marja Thorén
Journal:  Endocrine       Date:  2012-01-07       Impact factor: 3.633

4.  Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline.

Authors:  Phyllis W Speiser; Ricardo Azziz; Laurence S Baskin; Lucia Ghizzoni; Terry W Hensle; Deborah P Merke; Heino F L Meyer-Bahlburg; Walter L Miller; Victor M Montori; Sharon E Oberfield; Martin Ritzen; Perrin C White
Journal:  J Clin Endocrinol Metab       Date:  2010-09       Impact factor: 5.958

Review 5.  Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome.

Authors:  Henrik Falhammar; Anna Nordenström
Journal:  Endocrine       Date:  2015-06-17       Impact factor: 3.633

6.  Prevalence of ovarian adrenal rest tumours and polycystic ovaries in females with congenital adrenal hyperplasia: results of ultrasonography and MR imaging.

Authors:  Nike M M L Stikkelbroeck; Ad R M M Hermus; Diana Schouten; Harold M Suliman; Gerrit J Jager; Didi D M Braat; Barto J Otten
Journal:  Eur Radiol       Date:  2004-08-18       Impact factor: 5.315

Review 7.  [Testicular adrenal rest tumors (TART) in adult men with classic congenital adrenal hyperplasia (CAH)].

Authors:  P Knape; N Reisch; H-G Dörr; M Reincke; S Lenk; M Quinkler
Journal:  Urologe A       Date:  2008-12       Impact factor: 0.639

8.  Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Phyllis W Speiser; Wiebke Arlt; Richard J Auchus; Laurence S Baskin; Gerard S Conway; Deborah P Merke; Heino F L Meyer-Bahlburg; Walter L Miller; M Hassan Murad; Sharon E Oberfield; Perrin C White
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

Review 9.  Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.

Authors:  Hedi L Claahsen-van der Grinten; Phyllis W Speiser; S Faisal Ahmed; Wiebke Arlt; Richard J Auchus; Henrik Falhammar; Christa E Flück; Leonardo Guasti; Angela Huebner; Barbara B M Kortmann; Nils Krone; Deborah P Merke; Walter L Miller; Anna Nordenström; Nicole Reisch; David E Sandberg; Nike M M L Stikkelbroeck; Philippe Touraine; Agustini Utari; Stefan A Wudy; Perrin C White
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

10.  Testicular adrenal rest tumours in congenital adrenal hyperplasia.

Authors:  H L Claahsen-van der Grinten; A R M M Hermus; B J Otten
Journal:  Int J Pediatr Endocrinol       Date:  2009-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.